Published in Nouv Rev Fr Hematol on February 19, 1966
Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58
French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3. Support Care Cancer (2012) 1.45
[Transfusional strategy in neurosurgery: preoperative hemodilution by erythrocytapheresis]. Ann Fr Anesth Reanim (1994) 1.39
Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases. Atherosclerosis (1976) 1.32
Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. Br J Clin Pharmacol (1996) 1.24
Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas (1996) 1.23
[Hyperlipidemia caused by anti-beta-lipoprotein autoantibodies. A new pathological entity]. C R Acad Sci Hebd Seances Acad Sci D (1965) 1.21
Auto-immune hyperlipidemia. An atherogenic metabolic disease of immune origin. Rev Eur Etud Clin Biol (1970) 1.15
Antiethinyloestradiol antibody activities in oral contraceptive users. Clin Exp Immunol (1979) 1.12
Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease. J Clin Invest (1993) 0.99
Autoimmune hyperlipidemia. Atherosclerosis (1977) 0.98
Oral contraceptive, pulmonary artery thrombosis and anti-ethinyl-oestradiol monoclonal IgG. Clin Exp Immunol (1976) 0.98
Elastin-elastase-atherosclerosis revisited. Atherosclerosis (1998) 0.97
Oral contraception, circulating immune complexes, antiethinylestradiol antibodies, and thrombosis. Am J Reprod Immunol (1982) 0.93
[Contraceptive hormones, vascular risk and abnormal precipitation of serum gamma-globulins (author's transl)]. Pathol Biol (Paris) (1978) 0.91
Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients. Br J Clin Pharmacol (1991) 0.89
[Presence of an anti-beta-lipoprotein autoantibody in a myeloma serum]. C R Acad Sci Hebd Seances Acad Sci D (1965) 0.89
[Use of a detergent for the purification of antilipoprotein antibodies]. Immunochemistry (1970) 0.89
The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research. Ann Oncol (2012) 0.89
Tobacco and other factors in the etiology of ischemic heart disease in man: results of a retrospective survey. J Chronic Dis (1966) 0.89
Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa. Clin Exp Immunol (1980) 0.88
Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin A. Ther Drug Monit (1993) 0.88
[Gamma globulins and hyperlipemia. Hyperlipemia caused by autoantibodies]. Ann Biol Clin (Paris) (1970) 0.88
Effect of chronic glucagon administration on lipoprotein composition in normally fed, fasted and cholesterol-fed rats. Lipids (1991) 0.88
[A common specificity in serum alpha and beta-lipoproteins demonstrated by a myeloma auto-antibody. The Pg antigen]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.88
International consensus statement on olive oil and the Mediterranean diet: implications for health in Europe. The Olive Oil and the Mediterranean Diet Panel. Eur J Cancer Prev (1997) 0.87
A GLC method for estimation of chlorophenoxyisobutyric acid in plasma. Pharmacokinetics of a single oral dose of clofibrate in man. Eur J Clin Pharmacol (1975) 0.87
[Myeloma anti-lipoprotein autoantibodies. Comparative study of 2 types anti-Lp P.G. IgA and anti-Lp A.S. IgG]. Ann Biol Clin (Paris) (1970) 0.86
Lipoprotein kinetics in patients with analbuminemia. Evidence for the role of serum albumin in controlling lipoprotein metabolism. Arterioscler Thromb Vasc Biol (1997) 0.86
[Dyslipidemia in the diabetic patient. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)]. Diabete Metab (1995) 0.85
Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology (1999) 0.84
[Myeloma and hyperlipemia. IV. Nature of the specific anti-lipoprotein activity]. Nouv Rev Fr Hematol (1967) 0.83
[Myeloma, hyperlipemia and xanthomatosis]. Nouv Rev Fr Hematol (1965) 0.83
[Hyperlipidemia caused by auto-antibodies. A cause of atherosclerosis]. Presse Med (1967) 0.83
[Detection of pill-induced antiethinylestradiol antibodies (author's transl)]. Ann Biol Clin (Paris) (1981) 0.82
[Waldenström's macroglobulinemia with preserved antierythrocyte and antilipoprotein antibody activity]. Sem Hop (1975) 0.82
Detection and composition of circulating immune complexes in oral contraceptive users. Biomedicine (1979) 0.82
Oleic acid rich diet protects against the oxidative modification of high density lipoprotein. Free Radic Biol Med (1997) 0.82
Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles. Arterioscler Thromb Vasc Biol (1995) 0.82
Cholesterol synthesis by human fibroblasts in the presence of LDL and anti-LDL IgA. Biomedicine (1979) 0.82
Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome. Arterioscler Thromb Vasc Biol (1997) 0.82
A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition. Metabolism (1992) 0.82
[Passive hemagglutination with chromium chloride. Its use without macromolecular dilution]. Pathol Biol (Paris) (1969) 0.81
Diabetes mellitus in sand rats (Psammomys obesus). Metabolic pattern during development of the diabetic syndrome. Diabetes (1984) 0.81
Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids. Biochim Biophys Acta (1990) 0.81
[Experimental hyperlipemia induced by immunization in the rabbit]. Pathol Biol (1968) 0.81
[A myeloma gamma A-globulin with a specific anti-lipoprotein activity. The anti-Pg autoantibody]. C R Acad Sci Hebd Seances Acad Sci D (1966) 0.81
[Anti-heparin immunoglobulins, a factor of thrombosis, hyperlipemia and atherosclerosis]. Pathol Biol (Paris) (1974) 0.80
[A further case of hyperlipemia due to auto-antibodies. Its treatment with D-penicillamine]. Bull Mem Soc Med Hop Paris (1967) 0.80
Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients. Atherosclerosis (1995) 0.80
[A second type of myeloma antilipoprotein autoantibody: IgG anti-Lp A1]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.80
[Immunochemical study of the lipoprotein substance Pg (author's transl)]. Pathol Biol (Paris) (1977) 0.79
Prevalence of dyslipidemia in liver transplant recipients. Transplantation (1992) 0.79
Effects of different dietary intake of essential fatty acids on C20:3 omega 6 and C20:4 omega 6 serum levels in human adults. Lipids (1985) 0.79
Antiestrogen antibodies, oral contraception and systemic lupus erythematosus. Clin Physiol Biochem (1989) 0.79
[Blood triglycerides in a professional group]. J Atheroscler Res (1967) 0.79
Comparison between extra virgin olive oil and oleic acid rich sunflower oil: effects on postprandial lipemia and LDL susceptibility to oxidation. Ann Nutr Metab (1998) 0.79
Modification in the composition and metabolic properties of human low density and high density lipoproteins by different dietary fats. J Lipid Res (1984) 0.79
Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias. Artery (1982) 0.78
Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group. Br J Clin Pharmacol (1994) 0.78
[Method of purification of rabbit antibody against human beta lipoprotein starting with specific precipitates]. Immunochemistry (1969) 0.78
Plateletpheresis concentrates produced with the COMTEC cell separator: the French experience. Transfus Apher Sci (2001) 0.78
Inhibition of lipoprotein lipase activity by a monoclonal immunoglobulin in autoimmune hyperlipidemia. Atherosclerosis (1977) 0.78
The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia. Atherosclerosis (1985) 0.78
Immuno-metabolic factors in schistosomal hepatic fibrosis modulating atherogenesis. Ann Biol Clin (Paris) (1992) 0.78
Effects of three dietary fats on plasma lipids and lipoproteins in fasting and post-prandial humans after a short-term diet. Lipids (1980) 0.78
Influence of environmental medium on fatty acid composition of human cells: leukocytes and fibroblasts. Lipids (1987) 0.78
Dietary modifications of low-density lipoprotein fatty acids in humans: their effect on low-density lipoprotein-fibroblast interactions. Clin Physiol Biochem (1986) 0.78
In vitro interaction of LDL, anti-lipoprotein IgA and human fibroblasts. Biomedicine (1978) 0.78
[Purification of serum alpha-1-lipoproteins]. Ann Biol Clin (Paris) (1970) 0.78
[Cholestatic viral hepatitis A in adults. Clinical, biological and histopathological study of 9 cases]. Gastroenterol Clin Biol (1994) 0.78
[The specific activity of the M proteins. "Towards a new criterion for the classification of the myelomas and macroglobulinemias"]. Rev Fr Etud Clin Biol (1967) 0.78
A new serum lipoprotein associated erythrocyte antigen which reacts with a monoclonal IgM. The stored human red blood cell SHRBC antigen. Vox Sang (1976) 0.78
[Presence of a phospholipid in the Pg site that reveals IgA myelomatous antilipoprotein (anti-Pg) ]. C R Acad Sci Hebd Seances Acad Sci D (1968) 0.78
Asymptomatic homozygous hypobetalipoproteinemia associated with apolipoprotein B45.2. Hum Mol Genet (1994) 0.78
Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients. Clin Chim Acta (1999) 0.77
Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin. Atherosclerosis (1999) 0.77
[An anti-heparin immunoglobulin in a hyperlipidemic serum. (A new variety of auto-antibody hyperlipidemia)]. C R Acad Sci Hebd Seances Acad Sci D (1970) 0.77
Olive oil and the Mediterranean diet: implications for health in Europe. Br J Nurs (1997) 0.77
[Presence of an anti-beta-lipoprotein auto-antibody in the serum of a rabbit having a hyperlipidemia by immunization (hyperlipidemia by experimental auto-antibodies)]. C R Acad Sci Hebd Seances Acad Sci D (1969) 0.77
Dietary fats and lecithin-cholesterol acyltransferase activity in healthy humans. Ann Nutr Metab (1988) 0.77
Immunogenicity and the vascular risk of oral contraceptives. Br Heart J (1985) 0.77
Fluidity changes and chemical composition of lipoproteins in type IIa hyperlipoproteinemia. Biochim Biophys Acta (1990) 0.77
[A method for the purification of serum beta-lipoproteins]. Ann Biol Clin (Paris) (1968) 0.77
[Agglutination phenomenon of lipid particles. Its value in sero-immunology]. Pathol Biol (Paris) (1972) 0.77
Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia. Ann Nutr Metab (1991) 0.76
Influence of diet on the plasma levels and distribution of ApoA-I-containing lipoprotein particles. Prog Lipid Res (1991) 0.76
[The phenomenon of agglutination of lipid particles in hyperlipidemia by autoantibodies. Test of agglutination of activated lipid amulsions (AALE)]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.76
In vitro preparation of elastin--triglyceride complexes. Fatty acid uptake and modification of the susceptibility to elastase action. Atherosclerosis (1980) 0.76
Vascular thrombosis and oral contraceptives - a risk correlated study. J Med (1981) 0.76
Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases. Eur Heart J (1991) 0.76
Dietary monounsaturated fatty acids enhance cholesterol efflux from human fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition, and size of HDL3. Arterioscler Thromb (1993) 0.76
Increased cholesteryl ester transfer activity in plasma from analbuminemic patients. Arterioscler Thromb Vasc Biol (1996) 0.76